Back

Second generation cryoballoon ablation in paroxysmal atrial fibrillation patients: 24 month safety and efficacy from the STOP-AF post approval study

20 June 2017 (08:30 - 08:40)
Organised by:
Congress Presentation Part of: Rapid Fire session 5 - Catheter ablation: tools and technologies Catheter ablation (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Mr Robert Hokanson

Medtronic, Minneapolis (United States of America)

8 More presentations in this session

Presentation thumbnail
Esophageal thermal injury with contact force radiofrequency and cryoballoon ablation for atrial fibrillation
Associate Professor N. Akoum (Seattle, US)
Abstract Slides Video
Presentation thumbnail
Clinical validation of automatic local activation time annotation during idiopathic ventricular tachycardia ablation procedures
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Assessment of transmurality during lesion formation with electrograms
Doctor A. Porta-Sanchez (Barcelona, ES)
Abstract
Presentation thumbnail
Early feasibility results evaluating a multi-electrode radiofrequency ablation balloon catheter system in patients with symptomatic paroxysmal atrial fibrillation
Doctor M. Daly (Christchurch, NZ)
Abstract Slides Video
Presentation thumbnail
Sequential ultra-high density contact mapping shows increase of left atrial organization during persistent atrial fibrillation ablation
Doctor D. Latcu (Monaco, MC)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire session 5 - Catheter ablation: tools and technologies

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources